clinical trial · NCT07030400
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
H. Lee Moffitt Cancer Center and Research Institute·—·recruiting·n = 100
Small Lymphocytic Lymphoma (SLL)Chronic Lymphocytic Leukemia (CLL)Bruton's tyrosine kinase inhibitorB-Cell Lymphoma 2 Protein Inhibitor
brief summary
The study aims to improve our understanding of how quality of life, fatigue, and symptoms change over 2 years when participants are treated for chronic lymphocytic leukemia or small lymphocytic lymphoma. We will compare two types of treatment to help future patients with chronic lymphocytic leukemia or small lymphocytic lymphoma know what to anticipate.
started
Jul 17, 2025
primary completion
Jun 1, 2028
completion
Jun 1, 2028
last updated
Apr 1, 2026
official title
Predictors of Health-Related Quality of Life in Adults With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol